Senate deal reached to cap insulin costs

Four senators introduced bipartisan legislation Wednesday to cap monthly insulin costs at $35 for patients with private insurance coverage. The bill, called the INSULIN Act, was unveiled by Democrats Jeanne Shaheen of New Hampshire and Raphael Warnock of Georgia, alongside Republicans Susan Collins of Maine and John Kennedy of Louisiana. Insulin costs have become a major healthcare flashpoint, with many diabetics rationing doses due to high out-of-pocket expenses despite insurance coverage. The measure aims to limit what patients must pay directly for the drug, a significant portion of their total healthcare burden. The bipartisan sponsorship suggests potential pathway for the legislation in a divided Congress, though passage would still require broader Senate and House support.